13F-HR filed by CHI Advisors LLC
CHI Advisors LLC filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-12, with 13 holding rows worth $102,720,000.
- Accession
- 0001085146-19-002865
- Filer
- CIK 1791468
- Filed
- 2019-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2019
A holdings report, 13 entries on the cover page, a total value of $102,720,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $102,720,000 with VALUE read as thousands by filing date, 13F file number 028-19612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LIVONGO HEALTH INC | 539183103 | COM | 2,636,640 | $45,983,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 2,990,211 | $35,524,000 | thousands by filing date | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 1,083,786 | $9,093,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 727,260 | $2,356,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 28,000 | $1,359,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 18,000 | $1,322,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 390,307 | $1,175,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 22,464 | $1,171,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC COM | 903214104 | COM | 790,805 | $1,139,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 12,000 | $1,102,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 24,000 | $1,027,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 35,000 | $983,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 148,092 | $486,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-19-002865 | this filing | 2019-11-12 | acceptance time not in the bulk data set |